Return On Equity of Clearside Biomedical, Inc. from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Clearside Biomedical, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • Clearside Biomedical, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 55%, a 56% decline year-over-year.
  • Clearside Biomedical, Inc. annual Return On Equity for 2024 was 111%, a 73% decline from 2023.
  • Clearside Biomedical, Inc. annual Return On Equity for 2023 was 419%.
  • Clearside Biomedical, Inc. annual Return On Equity for 2022 was -153%, a 9477% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Clearside Biomedical, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 55% -71% -56% 01 Jul 2025 30 Sep 2025
Q2 2025 66% -104% -61% 01 Apr 2025 30 Jun 2025
Q1 2025 83% -168% -67% 01 Jan 2025 31 Mar 2025
Q4 2024 111% -308% -73% 01 Oct 2024 31 Dec 2024
Q3 2024 126% -3179% -96% 01 Jul 2024 30 Sep 2024
Q2 2024 170% +704% 01 Apr 2024 30 Jun 2024
Q1 2024 252% +494% 01 Jan 2024 31 Mar 2024
Q4 2023 419% +572% 01 Oct 2023 31 Dec 2023
Q3 2023 3306% +3322% 01 Jul 2023 30 Sep 2023
Q2 2023 -534% -528% -9106% 01 Apr 2023 30 Jun 2023
Q1 2023 -242% -243% -78078% 01 Jan 2023 31 Mar 2023
Q4 2022 -153% -155% -9477% 01 Oct 2022 31 Dec 2022
Q3 2022 -16% +146% +90% 01 Jul 2022 30 Sep 2022
Q2 2022 -5.8% +167% +97% 01 Apr 2022 30 Jun 2022
Q1 2022 0.31% +220% 01 Jan 2022 31 Mar 2022
Q4 2021 1.6% +212% 01 Oct 2021 31 Dec 2021
Q3 2021 -162% -8.3% -5.4% 01 Jul 2021 30 Sep 2021
Q2 2021 -173% +17% +8.7% 01 Apr 2021 30 Jun 2021
Q1 2021 -220% -55% -33% 01 Jan 2021 31 Mar 2021
Q4 2020 -210% +36% +15% 01 Oct 2020 31 Dec 2020
Q3 2020 -153% +163% +51% 01 Jul 2020 30 Sep 2020
Q2 2020 -189% +86% +31% 01 Apr 2020 30 Jun 2020
Q1 2020 -165% +52% +24% 01 Jan 2020 31 Mar 2020
Q4 2019 -247% -96% -64% 01 Oct 2019 31 Dec 2019
Q3 2019 -316% -174% -122% 01 Jul 2019 30 Sep 2019
Q2 2019 -276% -139% -102% 01 Apr 2019 30 Jun 2019
Q1 2019 -217% -86% -65% 01 Jan 2019 31 Mar 2019
Q4 2018 -150% -19% -15% 01 Oct 2018 31 Dec 2018
Q3 2018 -142% -52% -57% 01 Jul 2018 30 Sep 2018
Q2 2018 -137% -71% -108% 01 Apr 2018 30 Jun 2018
Q1 2018 -131% -78% -147% 01 Jan 2018 31 Mar 2018
Q4 2017 -131% 01 Oct 2017 31 Dec 2017
Q3 2017 -91% 01 Jul 2017 30 Sep 2017
Q2 2017 -66% 01 Apr 2017 30 Jun 2017
Q1 2017 -53% 01 Jan 2017 31 Mar 2017

Clearside Biomedical, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 111% -308% -73% 01 Jan 2024 31 Dec 2024
2023 419% +572% 01 Jan 2023 31 Dec 2023
2022 -153% -155% -9477% 01 Jan 2022 31 Dec 2022
2021 1.6% +212% 01 Jan 2021 31 Dec 2021
2020 -210% +36% +15% 01 Jan 2020 31 Dec 2020
2019 -247% -96% -64% 01 Jan 2019 31 Dec 2019
2018 -150% -19% -15% 01 Jan 2018 31 Dec 2018
2017 -131% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.